Correction: Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer

Josefa P. Alameda; Miriam Gaspar; Ángel Ramírez; Manuel Navarro; Angustias Page; Cristian Suárez-Cabrera; M. Guadalupe Fernández; Jose R. Mérida; Jesús M. Paramio; Rosa A. García-Fernández; M. Jesús Fernández-Aceñero; M. Llanos Casanova

doi:10.18632/oncotarget.20001

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer

Josefa P. Alameda, Miriam Gaspar, Ángel Ramírez, Manuel Navarro, Angustias Page, Cristian Suárez-Cabrera, M. Guadalupe Fernández, Jose R. Mérida, Jesús M. Paramio, Rosa A. García-Fernández, M. Jesús Fernández-Aceñero and M. Llanos Casanova _

PDF | How to cite

Oncotarget. 2017; 8:53886-53886. https://doi.org/10.18632/oncotarget.20001

Metrics: PDF 2215 views | ?

Present: The grant support information is incomplete.

Corrected: The complete grant support is given below.

FUNDING

This research was supported partially by funds from Fondo Europeo de Desarrollo Regional (FEDER) and by grants from the Ministry of Economy and Competitiveness of Spain (PI13/02580 and PI14/01403, from the Instituto de Salud Carlos III to M.L. Casanova and A. Ramírez respectively) and by grants 1.010.511 (Fundación Banco de Santander-Universidad Alfonso X el Sabio) to M.J Fernández-Aceñero; Comunidad Autónoma de Madrid grant S2010/BMD-2470 (Oncocycle Program) and CIEM13-4E-1944 to JMP; AES grants ISCIII-RETIC RD06/0020/0029 and RD12/0036/0009 to JMP.

Original article: Oncotarget. 2016; 7:29531-47. DOI:10.18632/oncotarget.8792.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20001

Publication Alerts

Corrections:

Correction: Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer